Clinical Trials Directory

Trials / Completed

CompletedNCT03993093

Prevalence of HIV +ve Cases With AIDS Defining Opportunistic Infections Among ART Naive Patients Attending ART Centre

AIDS Defining Opportunistic Infections in Naive HIV Cases

Status
Completed
Phase
Study type
Observational
Enrollment
257 (actual)
Sponsor
Singh, Ranjan Kumar, M.D. · Individual
Sex
All
Age
5 Years
Healthy volunteers
Not accepted

Summary

HIV patients are likely to suffer from opportunistic infections, in absence of highly active retroviral therapy. This happens due to lack of awareness of HIV status among patients or unresponsive to anti retroviral drugs. This study is for the prevalence of AIDS defining OIs among treatment naive HIV patients.

Detailed description

Oppotunistic infections (OIs) happen in persons with weakened immune system. HIV patients, who remain untreated due to lack of knowledge of existing HIV infections, often get OIs. HIV patients with AIDS defining OIs fall into stage 3 of HIV illness. Prevalence of OIs in resource poor settings are tuberculosis (pulmonary and extra pulmonary), toxoplasmosis, cryptococcosis, and oesophageal candidiasis. There are a few data to show AIDS defining OIs in treatment naïve HIV patients. Incidence of OIs among HIV patients in United States, and Canada between 2000 to 2019 was 9%. Leading OIs were peumocystis Jiroveci, oesophageal candidiasis and disseminated MAC or M. kansassi. Minimal diagnoses at poor settings can be made by observation of symptoms, use of microscope, imaging and diagnostic therapy.

Conditions

Interventions

TypeNameDescription
OTHERCD4 cell countCD4 cell count from treatment naive HIV patients

Timeline

Start date
2019-06-01
Primary completion
2020-02-28
Completion
2020-03-15
First posted
2019-06-20
Last updated
2020-03-19

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT03993093. Inclusion in this directory is not an endorsement.

Prevalence of HIV +ve Cases With AIDS Defining Opportunistic Infections Among ART Naive Patients Attending ART Centre (NCT03993093) · Clinical Trials Directory